Saint-Cyr-Sur-Loire, France Clinical Trials — 12 Studies

Filter these 12 trials by phase, condition, sponsor and more.

Open in Search →

LEvOsimendaN vs. Placebo Before Tricuspid VAlve Surgery in Patients with Right Ventricular Dysfunction Pending

2024-516167-86-00 5 Patients referred for an isolated or a combined surgical correction of
A clinical trial to learn more about the effects of FWY003 in people with geographic atrophy associated with age-related macular degeneratio … Pending

2025-523704-77-00 4 Geographic atrophy secondary to age-related macular degeneration
Long–term Analysis of DImethyl fumarate, to slow the Growth of Areas of Geographic Atrophy Recruiting

2024-510741-33-00 4 2024-06-27 Macular degeneration
A Study to Determine Safety and Long-Term Effectiveness of Faricimab in Participants with Age-Related Macular Degeneration Recruiting

2024-517545-13-00 11 2025-06-04 Neovascular Age-Related Macular Degeneration
A randomized study to evaluate the Efficacy and Safety of Intravitreal EYE103 Compared to Anti-VEGF Ended recruitment

2025-520809-12-00 10 2025-10-16 Diabetic Macular Edema
A randomized study to evaluate the Efficacy and Safety of Intravitreal EYE103 Compared to Anti-VEGF (in patients with Diabetic Macular Edema … Ended recruitment

2024-510944-30-00 10 2024-11-22 Diabetic Macular Edema
Efficacy, safety, and dose-response of a Live Biotherapeutic Product (BGY-1601-VT, vaginal tablet) as a first-line monotherapy in women with … Ended

2023-508958-26-00 7 2024-10-16 Gynaecological
A Study to Evaluate the Efficacy and Safety of Faricimab in Patients with Choroidal Neovascularization Secondary to Pathologic Myopia Ended

2023-506707-25-00 5 2024-04-09 Choroidal neovascularization secondary to pathologic myopia
A study to learn how well a higher amount of aflibercept given as an injection into the eye works and how safe it is in people with reduced … Ended

2022-502174-16-00 5 2023-09-13 Macular edema secondary to retinal vein occlusion
An Open-Label Extension Study for Patients who Previously Completed Study ISEE2008 (GATHER2) Ended

2024-515185-13-00 5 2022-12-21 geographic atrophy
An Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan (APL-2) in Subjects with Geographic Atrophy Secondary to … Ended

2024-512945-18-00 5 2021-11-30 Geographic Atrophy Secondary to Age-Related Macular Degeneration
Cerebral neuroinflammation during major depressive episode: multicentric comparative study (InflaDep) Ended

2024-518405-18-00 6 2018-12-07 Depressive disorder

Showing 1–12 of 12 trials